Tim Smith

A pair of phase 3 clinical trials presented at EADV 2022 indicate dupilumab significantly improves PN symptoms over 24 weeks.

Large numbers of vitiligo patients around the world have reported differing outcomes, with darker skin types expressing the more significant severity, according to new findings.

Research presented at EADV 2022 sees positive outcomes with the targeted therapy for patients of varied backgrounds with vitiligo.

The pandemic may have both widened the vaccination coverage gap between rural and urban adolescents and affected vaccination coverage in general.

A research letter by Emory University investigators found racial disparities in temperature measurements for Black and White hospital patients.

Rebecca T. Brown, MD, MPH, describes contributing factors to older homeless adult mortality and future topics of interest in this field.

The latest indications for the novel selective antibody will make it available as a treatment for pustular psoriasis.

A study from Germany elucidated new information on the rare uncombable hair syndrome, changing the ways in which the syndrome may be analyzed.

Rebecca T. Brown, MD, MPH, discusses the growing prevalence of older homeless adults, and what diseases community leaders and caregivers are combating most frequently in them.

Recent research from George Washington University analyzed the effects of COVID-19 on recruitment and funding for medical school pathway programs.

An Oakland-based analysis of mortality among homeless adults aged ≥50 years old illuminates the need for more proactive homeless care policies.

A recent study developed framework to improve fall prevention methodology across the country’s primary health care system.

A recent study in Finland finds 2 major contributing factors to allergic disease in infants with familial risk.

A recent study indicated no evident VTE risk in patients with eczema, despite FDA black box warnings for the drug class.